311 results on '"Celada, F."'
Search Results
2. PO-1605 LATTICE radiotherapy: A one institution experience
3. Recommendations of the Spanish brachytherapy group (GEB) of Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM) for high-dose rate (HDR) non melanoma skin cancer brachytherapy
4. PO-1468 LATTICE radiotherapy: A one institution experience
5. A Discrete Model of Cellular/Humoral Responses
6. LATTICE radiotherapy: A one institution experience
7. PO-0225 Automatic reporting of vaginal dose points for cervical cancer HDR-brachytherapy
8. PO-0206 A dosimetric index to assess cervix brachytherapy implants: Dovix
9. PO-1323 Re-irradiation in NSCLC High-dose RT: Control, Survival and Toxicity
10. IMMSIM, a flexible model for in machina experiments on immune system responses
11. Does the Human Mind Use a Logic of Signs Developed by Lymphocytes 108 Years Ago?
12. Basic Principles of Antigen-Antibody Interaction
13. Could Aggregation of Human Immunoglobulins Bring about Appearance of Novel Antigenic Sites?
14. Novel simple templates for reproducible positioning of skin applicators in brachytherapy
15. Failure mode and effects analysis of skin electronic brachytherapy using Esteya (R) unit
16. Immunogenicity Decay of Foreign Antigens in the Mouse
17. Attempt to Separate Antibody-Forming Clones of Different Affinity for One Antigenic Determinant on a Macromolecule
18. Fetal dose measurements and shielding efficiency assessment in a custom setup of 192Ir brachytherapy for a pregnant woman with breast cancer
19. Recommendations of the Spanish brachytherapy group (GEB) of Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM) for high-dose rate (HDR) non melanoma skin cancer brachytherapy
20. PO-0726: Dose escalation with HDR brachytherapy for intermediate- and high-risk prostate cancer
21. Fetal dose measurements and shielding efficiency assessment in a custom setup of Ir-192 brachytherapy for a pregnant woman with breast cancer
22. Non-melanoma skin cancer treated with HDR Valencia applicator: clinical outcomes
23. Modelling the immune system with situated agents
24. Early Toxicity Outcomes: A Single 15-Gy Fraction High-Dose-Rate Brachytherapy as Pretreatment External Beam Radiation Therapy Boost in Prostate Cancer
25. PO-0978: Salvage iodine-125 brachytherapy for local prostate cancer recurrence after radiotherapy
26. EP-1613: Depth determination of skin cancers treated with superficial barchytherapy: ultrasound vs. histopathology
27. Early toxicity outcomes: A single 15Gy fraction HDR brachytherapy as pre-treatment EBRT boost in prostate cancer
28. EP-1590: Shielding design and fetal dose evaluation of a breast cancer pregnant patient undergoing HDR Ir-192 brachytherapy
29. PO-0723: Early toxicity outcomes: A single 15Gy fraction HDR brachytherapy as pre-treatment EBRT boost in prostate cancer
30. EP-1256: Salvage iodine-125 brachytherapy for local prostate cancer recurrence after radiotherapy
31. Polyspecificity of T cell and B cell receptor recognition
32. Basic Principles of Antigen-Antibody Interaction
33. The Cellular Basis of Immunologic Memory
34. Immunogenicity Decay of Foreign Antigens in the Mouse
35. The Cellular Basis of Immunologic Memory
36. HDR Valencia Applicator in Nonmelanoma Skin Cancer: Clinical Outcomes
37. EP-1948: Keloids treatment brachytherapy
38. EP-1897: Clinical outcomes and toxicity in MRI based cervical brachytherapy
39. 160Gy dose-escalation in I-125 prostate implants: Updated outcomes and toxicity
40. Stereotactic body radiation therapy for medically inoperable lung cancer
41. Outcome and toxicity using interstitial-MRI Utrecht applicator in cervical brachytherapy
42. Salvage I125 brachytherapy for local prostate cancer recurrence after radiotherapy
43. PO-0983: High dose rate hypofractionated in skin cancer using the Valencia applicator
44. PO-291 UTRECHT INTERSTITIAL CT/MRI APPLICATOR FOR MRI IMAGING GUIDED HDR-BRACHYTHERAPY: DOSE VOLUME ANALYSIS
45. PO-295 DOSIMETRIC GAIN OF UTRECHT INTERSTITIAL CT/MRI APPLICATOR IN CERVICAL CANCER HDR-BRACHYTHERAPY
46. PO-296 CLINICAL AND DOSIMETRIC RESULTS OF HDR BRACHYTHERAPY GUIDED WITH MRI
47. The anti-DNA story
48. Inhibitory activity of HIV envelope gp120 dominates over its antigenicity for human T cells
49. Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity
50. STUDY OF THE POSSIBLE CORRELATION BETWEEN BLOOD ANTIGENS AND HISTOCOMPATIBILITY IN MAN. I. PRODUCTION OF LEUKOAGGLUTININS BY REPEATED TRANSFUSIONS FROM ONE DONOR*
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.